A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy inT-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma
NCT 06514794 Brief Summary The main purpose of this study is to…
Read more arrow_forwardNCT 06514794 Brief Summary The main purpose of this study is to…
Read more arrow_forwardNCT 05279300 Brief Summary This is a first-in-human (FIH) study to evaluate…
Read more arrow_forwardNCT 03557619 Brief Summary A study to assess the effect of multiple…
Read more arrow_forwardNCT 05807035 Brief Summary Phase 1 trial to evaluate the feasibility of…
Read more arrow_forwardNCT 03486873 Brief Summary The purpose of this study is to…
Read more arrow_forwardNCT 05020678 Brief Summary This is a single arm, open-label, multi-center, Phase…
Read more arrow_forwardNCT 06092580 Brief Summary The aims of this clinical trial are (1)…
Read more arrow_forwardNCT 03212404 Brief Summary CK-301 (cosibelimab) is a fully human monoclonal antibody…
Read more arrow_forwardNCT 06179511 Brief Summary This is a modular, multicentre, open-label, Phase…
Read more arrow_forward